HSP90AA1, one of the HSP90 isoforms, showed a significant correlation with survival time in lung cancer patients by inhibiting the AKT1 and ERK pathways (Niu et al., 2021) and was upregulated in colorectal cancer (Szczuka et al., 2021). The gene discussed is AKT1; the disease is lung carcinoma.